Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
- PMID: 10029590
Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
Abstract
Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induced angiogenesis in athymic mice. By immunohistochemistry, those sites where bFGF-induced neovascularization was inhibited by IL-12 displayed accumulation of NK cells and the presence of IP-10-positive cells. Based on expression of the cytolytic mediators perforin and granzyme B, the NK cells were locally activated. Experimental Burkitt lymphomas treated locally with IL-12 displayed tumor tissue necrosis, vascular damage, and NK-cell infiltration surrounding small vessels. After activation in vitro with IL-12, NK cells from nude mice became strongly cytotoxic for primary cultures of syngeneic aortic endothelial cells. Cytotoxicity was neutralized by antibodies to IFN-gamma. These results document that NK cells are required mediators of angiogenesis inhibition by IL-12, and provide evidence that NK-cell cytotoxicity of endothelial cells is a potential mechanism by which IL-12 can suppress neovascularization.
Similar articles
-
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.Blood. 1996 May 1;87(9):3877-82. Blood. 1996. PMID: 8611715
-
Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.Cancer Res. 2000 Sep 1;60(17):4838-44. Cancer Res. 2000. PMID: 10987295
-
In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.J Immunol. 2003 Sep 15;171(6):2953-9. doi: 10.4049/jimmunol.171.6.2953. J Immunol. 2003. PMID: 12960319
-
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.J Exp Med. 1995 Oct 1;182(4):1045-56. doi: 10.1084/jem.182.4.1045. J Exp Med. 1995. PMID: 7561678 Free PMC article.
-
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.J Exp Med. 2001 Mar 19;193(6):661-70. doi: 10.1084/jem.193.6.661. J Exp Med. 2001. PMID: 11257133 Free PMC article.
Cited by
-
Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.Gut. 2007 Jan;56(1):107-14. doi: 10.1136/gut.2005.083477. Epub 2006 Aug 4. Gut. 2007. PMID: 16891358 Free PMC article.
-
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation.Blood. 2005 Jun 15;105(12):4561-8. doi: 10.1182/blood-2004-12-4618. Epub 2005 Feb 17. Blood. 2005. PMID: 15718415 Free PMC article.
-
A novel pro-angiogenic function for interferon-γ-secreting natural killer cells.Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2885-92. doi: 10.1167/iovs.14-14093. Invest Ophthalmol Vis Sci. 2014. PMID: 24713481 Free PMC article.
-
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.Oncotarget. 2015 Oct 20;6(32):32561-74. doi: 10.18632/oncotarget.4935. Oncotarget. 2015. PMID: 26359356 Free PMC article.
-
Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells.Front Oncol. 2023 May 10;13:1171794. doi: 10.3389/fonc.2023.1171794. eCollection 2023. Front Oncol. 2023. PMID: 37234993 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources